Uric acid, endothelial dysfunction and pre-eclampsia

Journal of Hypertension

Volumn 22, Issue 2, 2004, Pages 237-239

  Pipkin, Fiona Broughton ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

URIC ACID;

CHEMICAL REACTION; EDITORIAL; ENDOTHELIUM LESION; GENE MUTATION; HUMAN; HYPERURICEMIA; MOLECULAR DYNAMICS; NONHUMAN; OXIDATION; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL;

EID: 1342322674     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200402000-00002     Document Type: Editorial

References (40)

1. Kang D-H, Finch J, Nakagawa T, Karumanchi SA, Kanellis J, Granger J, Johnson RJ. Uric acid, endothelial dysfunction, and preeclampsia: searching for a pathogenetic link. J Hypertens 2004; 22:229-235.
2. The Scottish Executive Health Department, The National Institute for Clinical Excellence, and The Department of Health Social Services and Public Safety Northern Ireland. 'Why mothers die': Report on confidential enquiries into maternal deaths in the United Kingdom 1997-1999. London: RCOG Press; 2001.
3. Saftlas AF, et al. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990; 163:460-465.
4. Wu XW, et al. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 1992; 34:78-84.
5. Watanabe S, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity hypertension. 2002; 40:355-360.
6. Pijnenborg R, Implantation and immunology: maternal inflammatory and immune cellular responses to implantation and trophoblast invasion Reprod Biomed Online 2002; 4 (suppl 3):14-17.
7. Parks DA, Williams TK, Beckman JS. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. Am J Physiol Gastrointest Liver Physiol 1988; 254:G768-G774.
8. Friedl HP, et al. Role of oxygen radicals in tourniquet related ischemia reperfusion injury of human patients. Klin Wochenschr 1991; 69: 1109-1112.
9. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003; 108:1912-1916.
10. Wang Y, Walsh SW. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta 2001; 22: 206-212.
11. Johnson RJ, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190.
12. Chapman AB, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998; 54:2056-2063.
13. de Jong CL, et al. Decreased first trimester uric acid production in future preeclamptic patients. J Perinat Med 1997; 25:347-352.
14. Gallery ED, Brown MA. Control of sodium excretion in human pregnancy. Am J Kidney Dis 1987; 9:290-295.
15. Dunlop W, Davison J. The effect of normal pregnancy upon the renal handling of uric acid. Br J Obstet Gynaecol 1977; 84:13-21.
16. Edelstam G, et al. New reference values for routine blood samples and human neutrophilic lipocalin during third-trimester pregnancy. Scand J Clin Lab Invest 2002; 61:583-592.
17. Gallery ED, Hunyor SN, Gyory AZ. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. QJ Med 1979; 48:593-602.
18. Fievet P, et al. Plasma renin activity, blood uric acid and plasma volume in pregnancy-induced hypertension. Nephron 1985; 40:429-432.
19. Quinones Galvan A, et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 1995; 268:E1-E5.
20. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003; 88:2393-2398.
21. Dekker GA, Sibai BM. Early detection of preeclampsia. Am J Obstet Gynecol 1991; 165:160-172.
22. Masse J, et al. A prospective study of several potential biologic markers for early prediction of the development of preeclampsia. Am J Obstet Gynecol 1993; 169:501-508.
23. Lim K-H, et al. The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am J Obstet Gynecol 1998; 178:1067-1071.
24. Williams KP, Galerneau F. The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies. J Obstet Gynaecol Can 2002; 24:628-632.
25. Martin JN, et al. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999; 180:1407-1414.
26. Witlin AG, et al. Risk factors for abruptio placentae and eclampsia: analysis of 445 consecutively managed women with severe preeclampsia and eclampsia. Am J Obstet Gynecol 1999; 180:1322-1329.
27. Many A, et al. Xanthine oxidase/dehydrogenase is present in human placenta. Placenta 1996; 17:361-365.
28. Graham CH, et al. Adriana and Luisa Castellucci Award Lecture 1999: Role of oxygen in the regulation of trophoblast gene expression and invasion. Placenta 2000; 21:443-450.
29. Brosens JJ, Pijnenborg R, Brosens IA. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am J Obstet Gynecol 2002; 187:1416-1423.
30. Many A, et al. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000; 156:321-331.
31. Granger JP, et al. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002; 9:147-160.
32. Roberts JM, et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol 1989; 161:1200-1204.
33. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53-56.
34. Fukuda O, et al. Scanning electron microscopic study on the angioarchitecture of glomeruli in experimental toxemia of pregnancy in the rabbit. Artery 1987; 14:223-228.
35. Abitbol MM. A simplified technique to produce toxemia in the pregnant dog. Am J Obstet Gynecol 1981; 139:526-534.
36. Cavanagh D, et al. Pregnancy-induced hypertension: development of a model in the pregnant primate (Papio anubis). Am J Obstet Gynecol 1985; 151:987-999.
37. Kanayama N, et al. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod 2002; 8:1129-1135.
38. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 2002; 283:R29-R45.
39. Davisson RL, et al. Discovery of a spontaneous genetic mouse model of preeclampsia. Hypertension 2002; 39:337-342.
40. Wooding FBP, Flint APF. Placentation. In: Lamming GE (editor): Marshall's physiology of reproduction. London: Chapman & Hall; 1994, p. 233-460.